The U.S. Food and Drug Administration said it approved Boston-based Vertex Pharmaceuticals' Journavx for short-term pain that ...
Stefan Kertesz, a physician and addiction expert, says overaggressive cutbacks can harm some chronic pain patients.
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.
Drug experts Drs. Volkow and McLellan set out a road map to reverse the opioid epidemic in 2016. Find out how we're doing now ...
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...
Hosted by the Tulane University Center for Continuing Education, seminar brings together leading researchers and clinicians ...